PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

NCT04115410 · clinicaltrials.gov ↗

UNKNOWN

Status

4724

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung
Immune-Related Adverse Events

Interventions

DRUG: PD-1 inhibitor
DRUG: Chemotherapy Drugs, Cancer

Sponsor

Sungkyunkwan University

Collaborators

[object Object]